This question was closed without grading. Reason: Answer found elsewhere
Apr 5, 2022 01:27
2 yrs ago
17 viewers *
English term
at systemic exposure 8 times higher than
English to Arabic
Medical
Medical (general)
No other adverse developmental outcomes were observed in animal reproduction studies with nirmatrelvir at systemic exposures (AUC) greater than or equal to 3 times higher than clinical exposure at the authorized human dose of PAXLOVID (see Data).
In the pre- and postnatal developmental study, body weight decreases (up to 8%) were observed in the offspring of pregnant rats administered nirmatrelvir at maternal systemic exposure (AUC24) approximately 8 times higher than clinical exposures at the authorized human dose of PAXLOVID.
In the pre- and postnatal developmental study, body weight decreases (up to 8%) were observed in the offspring of pregnant rats administered nirmatrelvir at maternal systemic exposure (AUC24) approximately 8 times higher than clinical exposures at the authorized human dose of PAXLOVID.
Proposed translations
(Arabic)
4 | في التعرض السريري 8 مرات أعلى من |
TargamaT team
![]() |
Proposed translations
2 hrs
في التعرض السريري 8 مرات أعلى من
في التعرض السريري 8 مرات أعلى من
Something went wrong...